EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacokinetic modeling of sulfamethoxazole-trimethoprim and sulfadiazine-trimethoprim combinations in broilers

Marine Boulanger, Jean-François Taillandier, Jérôme Henri, Mathias Devreese, Siegrid De Baere, Aude A Ferran, Alexis Viel

Poultry Science · 2024-11 · 103 (11) · 104200

DOI: 10.1016/j.psj.2024.104200 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Poultry Science, 2024-11. Verfasst von Marine Boulanger und 6 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutic Innovations and Resistance (INTHERES), Université de Toulouse INRAE ENVT, Toulouse 31076, France; Fougères Laboratory, French Agency for …. Hauptthemen laut MEDLINE: Chickens, Sulfadiazine, Trimethoprim, Trimethoprim, Sulfamethoxazole Drug Combination. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Programming Initiative on Antimicrobial Resistance, ANR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sulfonamides (S) are old bacteriostatic antibiotics which are widely prescribed in combination with trimethoprim (TMP) for the treatment of various diseases in food-producing animals such as poultry. Nowadays, the 1:5 dose ratio of TMP/S used in broilers is a direct transposition of the ratio determined in Human decades ago for TMP/sulfamethoxazole (SMX), aiming to obtain a supposed synergistic plasma concentration ratio of 1:19. However, major pharmacokinetics (PK) differences exist according to the sulfonamide used in the combination. Here, we generated new PK data in broilers after a cross-over design with IV and the oral administration of 2 major sulfonamides, sulfadiazine (SDZ) and SMX, in combination with TMP, and analyzed the data via a population pharmacokinetic (popPK) modeling approach. Results showed that TMP has a greater plasma to tissue distribution than both sulfonamides with a higher volume of distribution (0.51 L/kg for SDZ, 0.62 L/kg for SMX and 3.14 L/kg for TMP). SMX has the highest elimination half-life (2.83 h) followed by SDZ and TMP (2.01 h and 1.49 h, respectively). The oral bioavailability of the 3 molecules was approximately 100%. Bodyweight could explain some of the inter-individual variability in the volume of distribution of SDZ and SMX and the clearance of SDZ and TMP, as heavier broilers have higher typical values. Monte Carlo simulations of a large virtual broiler population (n = 1,000) showed that the targeted plasma ratio of TMP:S of 1:19 was rarely or never reached at the individual level for both combinations at the marketed doses and greatly varies over time and between individuals, questioning the relevance of the 1:5 dose ratio for current formulations of TMP/S.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ChickensSulfadiazineTrimethoprimTrimethoprim, Sulfamethoxazole Drug CombinationAnimalsAdministration, OralDrug CombinationsAnti-Bacterial AgentsCross-Over StudiesMaleModels, BiologicalHalf-LifeFemaleBenzenesulfonamides

Stichwörter der Autor:innen

combinationdosage regimenpopulation pharmacokinetic modelingsulfonamidetrimethoprim

Substanzen

SulfadiazineTrimethoprimsulfadiazine, trimethoprim drug combinationTrimethoprim, Sulfamethoxazole Drug CombinationDrug CombinationsAnti-Bacterial AgentsBenzenesulfonamides

Autor:innen und Institutionen

  • Therapeutic Innovations and Resistance (INTHERES), Université de Toulouse INRAE ENVT, Toulouse 31076, France; Fougères Laboratory, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 10B rue…
  • Fougères Laboratory, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 10B rue Claude Bourgelat, Fougères 35306, France.
  • Department of Pathobiology, Laboratory of Pharmacology and Toxicology, Pharmacology and Zoological Medicine, Faculty of Veterinary Medicine, Ghent University, 9820, Merelbeke, Belgium.
  • Therapeutic Innovations and Resistance (INTHERES), Université de Toulouse INRAE ENVT, Toulouse 31076, France.
  • Fougères Laboratory, French Agency for Food, Environmental and Occupational Health & Safety (ANSES), 10B rue Claude Bourgelat, Fougères 35306, France. Electronic address: alexis.viel@anses.fr.

Förderung

  • Joint Programming Initiative on Antimicrobial Resistance
  • ANR

Zitieren

APA

Boulanger, M., Taillandier, J. F., Henri, J., Devreese, M., De Baere, S., Ferran, A. A., & Viel, A. (2024). Pharmacokinetic modeling of sulfamethoxazole-trimethoprim and sulfadiazine-trimethoprim combinations in broilers. Poultry Science, 103(11), 104200. https://doi.org/10.1016/j.psj.2024.104200

Vancouver

Boulanger M, Taillandier JF, Henri J, Devreese M, De Baere S, Ferran AA, et al. Pharmacokinetic modeling of sulfamethoxazole-trimethoprim and sulfadiazine-trimethoprim combinations in broilers. Poultry Science. 2024;103(11):104200. doi:10.1016/j.psj.2024.104200

BibTeX
@article{Boulanger2024,
  author = {Boulanger, Marine and Taillandier, Jean-François and Henri, Jérôme and Devreese, Mathias and De Baere, Siegrid and Ferran, Aude A and Viel, Alexis},
  title = {Pharmacokinetic modeling of sulfamethoxazole-trimethoprim and sulfadiazine-trimethoprim combinations in broilers},
  journal = {Poultry Science},
  year = {2024},
  volume = {103},
  number = {11},
  pages = {104200},
  doi = {10.1016/j.psj.2024.104200}
}
Kostenlos starten →